81283 Medicaid Rate by State

IFNL3 gene variant test (hepatitis C treatment response)

23 state Medicaid programs publish a fee-for-service rate for 81283 (iFNL3 gene variant test (hepatitis C treatment response)), ranging from $45.26 in Hawaii to $75.44 in Arkansas, with a median of 88.2% of the national Medicare amount.

The Rates plan

$29/mo7-day free trial

This page shows one representative rate per state for 81283. Full schedules include every locality, modifier, and age-band variant.

  • Every code on all 51 published schedules
  • Full-schedule CSV export
  • Full state Medicaid dental network lists
  • Email alerts when a state changes its rates
Start 7-day free trial

$29/mo after the trial. Cancel anytime.

Publishing states

23

Median % of Medicare

88.2%

Rate range

$45.26 - $75.44

81283 rates in every publishing state

StateMedicaid rate% of MedicarePrior authVintage
Arkansas$75.44102.8%--2026
Arizona$73.37100%--2026
California$58.6980%--2026
Connecticut$58.3679.5%Required2018
District of Columbia$58.7080%Not required2019
Delaware$71.9098%--2026
Georgia$60.3582.3%--2026
Hawaii$45.2661.7%--2025
Illinois$49.9768.1%--2024
Kansas$64.1287.4%--2018
Kentucky$73.37100%--2026
Massachusetts$64.7088.2%--2024
Minnesota$73.37100%--2019
Missouri$66.03--Required2026
Mississippi$66.0390%--2026
Montana$73.36100%--2026
North Dakota$73.37100%Required2026
New Jersey$58.7080%Not required2026
New Mexico$73.37100%--2024
Ohio$55.0375%--2019
Oregon$58.70*80%--2026
Virginia$66.3990.5%--2018
Washington$58.7080%--2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.

Related lab & imaging codes

Frequently asked questions

How much does Medicaid pay for 81283?

23 state Medicaid programs publish a fee-for-service rate for 81283 (iFNL3 gene variant test (hepatitis C treatment response)), ranging from $45.26 in Hawaii to $75.44 in Arkansas, with a median of 88.2% of the national Medicare amount. The full table on this page lists every publishing state's current rate.

Which state pays the most for 81283?

Arkansas publishes the highest Medicaid rate for 81283 at $75.44 (102.8% of the national Medicare amount). Hawaii publishes the lowest at $45.26.

Does 81283 require prior authorization under Medicaid?

3 of the 23 publishing states flag 81283 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".